Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic pain

Author:

Arthur Joseph1,Edwards Tonya1,Lu Zhanni1,Amoateng Doris Magdalene1,Koom-Dadzie Kwame1,Zhu Hongxu1,Long James1,Do Kim-Anh1,Bruera Eduardo1

Affiliation:

1. The University of Texas MD Anderson Cancer

Abstract

Abstract PURPOSE Data indicates that clinicians might be under-prescribing opioids for patients with chronic cancer pain, and this could impact adequate chronic pain management. Few studies have sought to understand healthcare provider (HCP) perceptions and practices regarding the prescription of opioids for chronic pain. We assessed HCP perceptions and practices regarding opioid prescription for patients with chronic pain since the onset of the COVID-19 pandemic. METHODS An anonymous cross-sectional survey was conducted among 186 HCPs who attended an opioid educational event in April 2021 and 2022. RESULTS 61/143(44%) opioid prescribers reported reluctance to prescribe opioids for chronic pain. In a multivariate logistic model, younger participants (log OR -0.04, 95% CI: -0.085, -0.004; p = 0.033) and pain medicine clinicians (log OR -1.89, CI: -3.931, -0.286; p = 0.034) were less reluctant, whereas providers who worry about non-medical opioid use (NMOU) were more reluctant to prescribe opioids (log OR 1.58 95% CI: 0.77–2.43; p < 0.001). 53/143(37%) respondents had experienced increased challenges regarding opioid dispensing at pharmacies, and 84/179(47%) reported similar experience by their patients. 54/178(30%) HCPs were aware of opioid-related harmful incidents to patients or their families, including incidents attributed to opioid misuse by a household or family member. CONCLUSION A significant number of opioid prescribers were reluctant to prescribe opioids for patients with chronic pain. Many reported challenges regarding dispensing of opioids at the pharmacies. These may be unintended consequences of policies to address the opioid crisis. Future measures should focus on addressing regulatory barriers without undermining the gains already made to combat the opioid crisis.

Publisher

Research Square Platform LLC

Reference42 articles.

1. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC;Caraceni A;Lancet Oncol,2012

2. Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015–2016;Seth P;MMWR Morb Mortal Wkly Rep,2018

3. Lipari, R.N. and A. Hughes, How People Obtain the Prescription Pain Relievers They Misuse, in The CBHSQ Report. 2013: Rockville (MD). p. 1–7.

4. Relationship between Nonmedical Prescription-Opioid Use and Heroin Use;Compton WM;N Engl J Med,2016

5. Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak;Wainwright JJ;Jama,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3